Additionally, hiPSCs from AML patients with MLL rearrangements have been successfully established, in which the mutations were preserved in the derived AML-iPSCs, while leukemic DNA methylation and the gene-expression profile were reset after reprogramming. This evidence concerns the gene KMT2A and acute myeloid leukemia.